Table Of Content

Author Index Ase, A. see UTSUNOMIYA, Y. CHANEZ, P. see VIGNOLA, A.M. Ase, S. see SHUUBO, N. CHARLESWORTH, J.A. see PEAKE, P.W. ABKEN, H. see REINHOLD, U. CHEN, Q.Y. see Row.ey, M.J. Apu, D. see Brooks, C.J. CHIANG, B.-L. see YE, Y.-L. AGosTonI, A. see CicarpI, M. CHIAPPARA, G. see VIGNOLA, A.M. AHLSTEDT, S. see DAHLMAN-HOGLUND, A. CuisA, S. see Tsutsumi, H. Akimoto, Y. see ISHTYAMA, T. CHoMaRAT, P. see RissoAN, M.C. At-MUGHALES, J., BLyTH, T.H., HUNTER, J.A. & WILKINSON, P.C. The CHOUTEAU, P. see PERRAUT, R. chemoattractant activity of rheumatoid synovial fluid for human CHUANG, Y.-H. see YE, Y.-L. lymphocytes is due to multiple cytokines, 230 Cicarpi, M., Beretta, A., Cocomso, M., Giorrré, D., CuGNo, M. & A.onso, C. see Soto, M. Acostoni, A. Relevance of lymphoproliferative disorders and of ALVAREZ, F. see PAREZ, N. anti-Cl inhibitor autoantibodies in acquired angio-oedema, 475 AMRAOUI, Z. see MARCHANT, A. Cuerici, M. see MArzi, M. APOSTOLAKOS, P. see NEWKIRK, M.M. Cocng, M. see Decourt, C. AriIzono, N., NisHipa, M., UcHiKAWA, R., YAMADA, M., MatsupaA, S., Cotomso, M. see Cicarpi, M. TeGcosHi, T., Kirumura, Y. & SasaBe, M. Lung granulomatous Cooper, P.J., GUDERIAN, R.H., PRAKASH, D., Remick, D.G., EsPINeL, response induced by infection with the intestinal nematode Nippo- I., NuTMAN, T.B., TAYLor, D.W. & GrirFin, G.E. RANTES in strongylus brasiliensis is suppressed in mast cell-deficient Ws/Ws rats, 55 onchocerciasis: changes with ivermectin treatment, 462 AzuMaA, M. see KANEKO, H. CosMan, D. see LEELAYUWAT, C. CourerT, I. see JORGENSEN, C. BANCHEREAU, J. see RissoAN, M.C. CouTELigrR, J.-P. see Pottier, Y. Barc ay, A. see PoTTier, Y. CucGno, M. see Cicarp1, M. Barst, R.J. see Morse, J.H. BASKIN, B., PETTERSSON, E., REKOLA, S., SmitH, C.I.E. & IsLam, K.B. Dramico, R. see DEREVIANKO, A. Studies of the molecular basis of IgA production, subclass regulation DaFFALLA, A.A. see Satti, M.Z. and class-switch recombination in IgA nephropathy patients, 509 DAHLGREN, C. see EBENFELT, A. BAUGHMAN, S. see MACANovic, M. DAHLGREN, U. see DAHLMAN-HOGLUND, A. : BELLIA, V. see VIGNOLA, A.M. DAHLMAN-HOGLUND, A., AHLSTEDT, S., HANSON, L.A., DAHLGREN, U. BENBERNOU, N. see ESNAULT, S. & Texemo, E. Different expression of IL-2 receptor a-chain on a BeretTA, A. see CICARDI, M. lamina propria T cell population and goblet cells in rats orally BERNSTEIN, C.N., SARGENT, M., GALLATIN, W.M. & Wixkins, J. (>- tolerized or sensitized to ovalbumin (OA) after colonization with integrin/intercellular adhesion molecule (ICAM) expression in the an OA-producing Escherichia coli, 534 normal human intestine, 160 DALLEGRI, F. see OTTONELLO, L. Biytu, T.H. see AL-MUGHALES, J. Dapino, P. see OTTONELLO, L. BociAn, R.C. see Moss, R.B. Davip, M. see GILHAR, A. Borre, G. see GRANGER, D. Davis, L.S. see ScHULZE-Koops, H. BoiTELLe, A. see VANHEE, D. DawkIns, R. see LEELAYUWAT, C. BoLoGna, C. see JORGENSEN, C. Decourt, C., CoGné, M. & Rocca, A. Structural peculiarities of a BONNEMAINS, B. see PERRAUT, R. truncated Vay; immunoglobulin light chain in myeloma with light BONSIGNORE, G. see VIGNOLA, A.M. chain deposition disease, 357 Bousquet, J. see VIGNOLA, A.M. Dec.t-Esposti, M.A.. see LEELAYUWAT, C. Bova.L-BoizarD, B. see Liote, F. De.iprias, C.C. see MounHous, A. Boyer, V. see MounHous, A. DerREVIANKO, A., D’amico, R. & Simms, H. Polymorphonuclear leuco- Borner, H., OSMAN, A.A., MEERGANS, TH., WEISKE, T. & Motues, TH. cyte (PMN)-derived inflammatory cytokines—regulation by oxygen Isolation of antigens recognized by coeliac disease autoantibodies tension and extracellular matrix, 560 and their use in enzyme immunoassay of endomysium and reticulin DUKHUIZEN, S. see Hommes, D.W. antibody-positive human sera, 344 Dona, Y.-J. see Moss, R.B. Brocuier, J. see JORGENSEN, C. Dusost, J.-J., PERRIER, S., AFANE, M., VIALLARD, J.-L., Roux-LOMBARD, Brooks, C.J., Kinc, W.J., RApForp, D.J., Apu, D., McGratu, M. & P., BAUDET-PoMMEL, M., BeGug, C., KEMENY, J.-L. & SAUVEZzIE, B.: Savace, C.O.S. IL-1 production by human polymorphonuclear IL-1 receptor antagonist in saliva; characterization in normal saliva leucocytes stimulated by anti-neutrophil cytoplasmic autoanti- and reduced concentration in Sjégren’s syndrome (SS), 237 bodies: relevance to systemic vasculitis, 273 DurRAnb, I. see RissoAN, M.C. Brostrom, C., SONNERBORG, A., Kim, S. & SALLBERG, M. Site-directed serology of HIV-1 subtype B infection: relation between virus specific EBENFELT, A., LUNpavist, H., DAHLGREN, C. & LUNDBERG, C. Neu- antibody levels and disease progression, 35 trophils in mucosal secretion are functionally active, 404 BruuN, J.A. see SUTMULLER, M. Eaipo, J. see GONZALEZ-CUADRADO, S. Bruyns, C. see MARCHANT, A. E1s_, M.M. see Oxe.tus, V.-A. Bustos, C. see GONZALEZ-CUADRADO, S. EKLUND, A. see SKOLD, C.M. BuURMAN, W.A. see MARCHANT, A. Exstun, G.L. see SUTMULLER, M. EsNAULT, S., BENBERNOU, N., LAVAuD, F. & GuENouNOou, M. Sponta- Canovas, F. see JORGENSEN, C. neous CD30 mRNA expression in peripheral blood mononuclear CARBON, G. see VOSWINKEL, J. cells from atopic patients with high IgE serum levels, 67 CARTWRIGHT, R.J. see Hitt, M.B. EspIneEL, I. see Cooper, P.J. CARVALHO, D. see HEALY, C.M. FATENEJAD, S. & Crart, J. Intrastructural help in diversification of CHABoT, B. see GRANGER, D. humoral autoimmune responses, | 578 Author Index FERNANDEZ, E. see Nieto, M. Hearty, C.M., CarRvALHO, D., PEARSON, J.D. & THORNHILL, M.H. Ferrer, J. see Torcat, J. Raised anti-endothelial cell autoantibodies (AECA), but not anti- Frers, W. see MARCHANT, A. neutrophil cytoplasmic autoantibodies (ANCA), in recurrent oral Fiscuer, E. see Mounous, A. ulceration: modulation of AECA binding by tumour necrosis factor- FLAasTer, E. see Morse, J.H. alpha (TNF-a) and interferon-gamma (IFN-7), 523 Fortino, M. see Morse, J.H. HELLsTROM, S. see OLOFSSON, K. Fournier, M.-J. see NewkirK, M.M. Herzoa, D. see PAREz, N. Friepricn, C. see Gerwin, N. Hitt, M.B., Puipps, J.L., CARTwriGHt, R.J., MILFORD WARD, A., Fritz_er, M.J. see Morse, J.H. Greaves, M. & HuGues, P. Antibodies to membranes of endothelial FrosteGArD, J. see HUANG, Y.H. cells and fibroblasts in scleroderma, 491 Fukucul, K. see IsHtyAMa, T. Hitt, T.J. see MANICKASINGHAM, S.P. Hinopa, Y. see SHuuso, N. GALIBERT, L. see Rissoan, M.C. Hirano, K. see UTsuNomiya, Y. GALLATIN, W.M. see BERNSTEIN, C.N. HOoLLINGswortH, P. see LEELAYUWAT, C. GARDNER, P. see Moss, R.B. HomeeraG, J.-C. see PAREz, N. HomMEL, G. see KAHALY, G. Gause, A. see VOSWINKEL, J. GEMMELL, E. see YAMAZAKI, K. Hommes, D.W., MEENAN, J., DukHuizeN, S., TEN KATE, F.J.W., Tytocat, G.N.J. & VAN DEVENTER, S.J.H. Efficacy of recombinant GENDRON, M. see GRANGER, D. granulocyte colony-stimulating factor (rhG-CSF) in experimental Georce, A.J.T. see Levy, J.B. Gerwin, N., Frieprich, C., Perez-Ataype, A., Rosen, F.S. & colitis, 529 GuTieERREz-Ramos, J.C. Multiple antigens are altered on T and B Honma, K. see SHimojo, N. lymphocytes from peripheral blood and spleen of patients with Hopr, T. see VOSWINKEL, J. Wiskott—Aldrich syndrome, 208 Horie, T. see Gon, Y. Gua.is, H.W. see Sati, M.Z. Horie, T. see Yosuipa, S. Gityar, A. Davin, M., Kauisu, R.S. & Weisincer, G. Jn vivo effects of Hosui0KA, A. see SHimojo, N. cytokines on psoriatic skin grafted on nude mice: involvement of the Hsu, Y.-P. see Moss, R.B. tumour necrosis factor (TNF) receptor, 134 Huanc, Y.H., SCHAFER-ELINDER, L., OwMAN, H., LoRENTZEN, J.C., Giorrre, D. see Cicarpi, M. RONNELID, J. & FrosteGArb, J. Induction of IL-4 by platelet- GoLpMAN, M. see MARCHANT, A. activating factor, 143 Gomez, L.C. see Soto, M. Huaues, P. see Hitt, M.B. Gon, Y., Hasurmoro, S., Hayasui, S., Koura, T., Matsumoto, K. & Hunter, J.A. see AL-MUGHALEs, J. Horie, T. Lower serum concentrations of cytokines in elderly Hussaln, R. see KiFAYET, A. patients with pneumonia and the impaired production of cytokines by peripheral blood monocytes in the elderly, 120 Ikal, M., Iron, M., Jon, T., YoKoyAMA, Y., OKADA, N. & Oxapba, H. GoNZALEZ-AMARO, R. see Nieto, M. Complement plays an essential role in shock following intestinal GoNZALEZ-CUADRADO, S., Bustos, C., Ruiz~-Orteca, M., Ortiz, A., ischaemia in rats, 156 Guuarro, C., Praza, J.J. & Ecipo, J. Expression of leucocyte Imal, K. see SHuuso, N. chemoattractants by interstitial renal fibroblasts: up-regulation by IMASAWA, T. see UTSUNOoMIYA, Y. drugs associated with interstitial fibrosis, 518 Isaacs, J.D., Winc, M.G., GREENwoop, J.D., HAZLEMAN, B.L., HALE, Gossett, P. see VANHEE, D. G. & WALDMANN, H. A therapeutic human IgG4 monoclonal anti- Grancer, D., GENDRON, M., TremBLAy, A., CHABOT, B., MENARD, body that depletes target cells in humans, 427 H.A. & Boire, G. RNA-labelled Ro and La ribonucleoprotein IsHIYAMA, T., Korke, M., Akimoto, Y., Fukucui, K., WATANABE, K.., complexes reassembled in vitro; characterization by gel shift analy- YosHipaA, M., WAKABAYASHI, Y. & TsuRUOKA, N. Heat shock- sis, 498 enhanced T cell apoptosis with heat shock protein 70 on T cell Greaves, M. see Hitt, M.B. surface in multicentric Castleman’s disease, 351 GREENSTEIN, J.D. see PEAKE, P.W. IsLaM, K.B. see BASKIN, B. Greenwoop, J.D. see Isaacs, J.D. Ito, M.R. see TANIGUCHI, Y. Grirrin, G.E. see Cooper, P.J. Ito, M., WATANABE, M., Kamiya, H. & Sakurai, M. Inhibition of GuDERIAN, R.H. see Cooper, P.J. natural killer (NK) cell activity against varicella-zoster virus (VZV)- GuENOUNOU, M. see EsNAULT, S. infected fibroblasts and lymphocyte activation in response to VZV GuEYDAN, C. see MARCHANT, A. antigen by nitric oxide-releasing agents, 40 Guuarro, C. see GONZALEZ-CUADRADO, S. Ito, O. see HARADA, M. GUTIERREZ-Ramos, J.C. see Gerwin, N. Iron, M. see Ika1, M. Guzman, F. see Soto, M. Ivanyl, J. see VORDERMEIER, H.M. Gomez, M. see Nieto, M. Hate, G. see Isaacs, J.D. Jacgz-AlIGRAIN, E. see PAREz, N. HALLDEN, G. see SKOLD, C.M. Jou, T. see Ikai, M. JORGENSEN, C., Couret, I., CANovas, F., BoLoGNa, C., Brocuier, J., HALLGREN, M. see SKOLD, C.M. Reme, T., Lipsky, P. & Sany, J. Mononuclear cell retention in HAMANO, S. see HARADA, M. rheumatoid synovial tissue engrafted in severe combined immuno- HAMMARSTROM, M.-L. see OLorsson, K. deficient (SCID) mice is up-regulated by tumour necrosis factor- Hanson, L.A. see DAHLMAN-HOGLUND, A. alpha (TNF-a) and mediated through intercellular adhesion mole- Hara, K. see YAMAZAKI, K. cule-1 (ICAM-1), 20 HaraDA, M., SumicuikA, H., HAMANo, S., Ito, O., TAMADA, K., TAKENOYAMA, M., Kimura, G. & Nomoto, K. IL-3 derived from CD4" Tc ells is essential for the in vitro expansion of mast cells from KaHaLy, G., Pitz, S., MOLLER-FoRELL, W. & HomMMEL, G. Randomized the normal adult mouse spleen, 149 trial of intravenous immunoglobulins versus prednisolone in Graves’ Harris, D.P. see VorDERMEIER, H.M. ophthalmopathy, 197 Hasuimorto, H. see KANEKO, H. KALDEN, J.R. see TsuZAKA, K. Hasuimoro, S. see Gon, Y. KALisH, R.S. see GILHAR, A. Hasuimoro, S. see YOsHIDA, S. Kamiya, H. see Ito, M. Hayasul, S. see Gon, Y. KanpbaA, N., Tsucuipa, T. & TAMAKI, K. Testosterone inhibits immu- HAZLEMAN, B.L. see Isaacs, J.D. noglobulin production by human peripheral blood mononuclear He, S. see WHALEY, K. cells, 410 Author Index 579 KANEKO, H., Sarto, K., HasHimoto, H., YaGiTA, H., OkumurRA, K. & MARCHANT, A. AMRAOuI, Z. GUEYDAN, C., BRuyNns, C., LE Morne, O. Azuma, M. Preferential elimination of CD28" T cells in systemic VANDENABEELE, P., Fiers, W., BUURMAN, W.A. & GOLDMAN, M. lupus erythematosus (SLE) and the relation with activation-induced Methylprednisolone differentially regulates IL-10 and tumour necro- apoptosis, 218 sis factor (TNF) production during murine endotoxaemia, 91 KATSUKI, T. see SHIMoJO, N. MaruyAaMA, N. see UtTsuNomiya, Y. KAUFMAN, J. see LEELAYUWAT, C. Marzi, M., VIGANO, A., TRABATTONI, D., ViLLA, M.L., SALVAGGIO, A.., KAVANAUGH, A.F. see SCHULZE-Koops, H. Cuerici, E. & Cierici, M. Characterization of type 1 and type 2 KAWAKAMI, K., QIFENG, X., TOHYAMA, M., QuresHI, M.H. & Sarto, A. cytokine production profile in physiologic and pathologic human Contribution of tumour necrosis factor-alpha (TNF-a) in host pregnancy, 127 defence mechanism against Cryptococcus neoformans, 468 Masson, P.L. see Pottier, Y. KAWAMURA, T. see UTSUNOMIYA, Y. MatsuDA, K. see TsutTsuMI, H. KAZATCHKINE, M.D. see Mounous, A. Matsupa, S. see ARIZzONO, N. Kemna, M. see Moss, R.B. Matsumoto, K. see Gon, Y. Kie.y, P.D.W., Ovprien, D. & Oxiverra, D.B.G. Anti-CD8 treatment McGrath, M. see Brooks, C.J. reduces the severity of inflammatory arthritis, but not vasculitis, in MEENAN, J. see Hommes, D.W. mercuric chloride-induced autoimmunity, 280 MEERGANS, TH. see BORNER, H. Kreny, M.P. see PERRAUT, R. MENARD, H.A. see GRANGER, D. KirayYet, A., SHAHID, F., Lucas, S. & Hussain, R. Erythema nodosum MERENDINO, A. see VIGNOLA, A.M. leprosum is associated with up-regulation of polyclonal IgG1 anti- MILFORD WARD, A. see Hitt, M.B. body synthesis, 447 Miossec, P. see Rissoan, M.C. Kin, S. see BRostrOm, C. Miraral, T. see UTsuNomiya, Y. Kimura, G. see HARADA, M. MoLET, S. see VANHEE, D. KinG, W.J. see Brooks, C.J. Moos, C. see PERRAUT, R. KIsHoRE, U. see WANG, J.Y. Monrl, S. see TANIGUCHI, Y. KiTuMURA, Y. see ARIZONO, N. Morioka, T. see NARISAWA-SaITO, M. KJELDSEN, M. see YAMAZAKI, K. Morone, P. see OTTONELLO, L. KNow Les, W.J. see Rowey, M.J. Morse, J.H., BAarst, R.J., Fotiwo, M., ZHANG, Y., FLASTER, E. & KosAYASHI, T. see YOSHIDA, S. Fritz_er, M.J. Primary pulmonary hypertension: immunogenetic Kouno, Y. see SHimojo, N. response to high-mobility group (HMG) proteins and histone, 389 Koike, M. see IsHtyAMA, T. Moss, R.B., BociAn, R.C., Hsu, Y.-P., Done, Y.-J., KEMNA, M., WEI, Koizumi, A. see YOSHIDA, S. T. & Garpner, P. Reduced IL-10 secretion by CD4* T lymphocytes Koura, T. see Gon, Y. expressing mutant cystic fibrosis transmembrane conductance reg- Kuntz, D. see Lioté, F. ulator (CFTR), 374 Motes, TH. see BORNER, H. Mounous, A., Deviprias, C.C., Fischer, E., Boyer, V. & KAZATCH- LACHMANN, P.J. see MAcANovic, M. KINE, M.D. Ligation of CR1 (C3b receptor, CD35) on CD4* T LACHMANN, P.J. The in vivo destruction of antigen a tool for probing lymphocytes enhances viral replication in HIV-infected cells, 297 and modulating an autoimmune response, 187 MULLBERG, J. see LEELAYUWAT, C. LarRRAD, L. see Torcat, J. MULLER-FoRELL, W. see KAHALY, G. LAvAuD, F. see ESNAULT, S. LE MOINE, O. see MARCHANT, A. NAKAJIMA, T. see YAMAZAKI, K. LEELAYUWAT, C., HOLLINGSWoRTH, P., PUMMER, S., LERTMEMONG- NAKAYAMA, T. see YOSHIDA, S. KOLCHAI, G., THOM, G., MULLBERG, J., Witt, C., KAuFMan, J., Dec.i-Esposti, M.A.., CosMAN, D. & DAwkins, R. Antibody reac- NARISAWA-SAITO, M., YAMANASHI, Y. Morioka, T., Orre, T. & SHimizu, F. Thy-1 molecule associates with protein tyrosine kinase(s) in rat tivity profiles following immunization with diverse peptides of the mesangial cells, 86 PERBI11 (MIC) family, 568 NAVARRO-ZORRAQUINO, M. see TorCAL, J. LERTMEMONGKOLCHAI, G. see LEELAYUWAT, C. Levy, J.B., TURNER, A.N., GeorGce, A.J.T. & Pusey, C.D. Epitope Newkirk, M.M., Novick, J., STEVENSON, M.M., Fournier, M.-J. & AposToLakos, P. : Differential clearance of glycoforms of IgG in analysis of the Goodpasture antigen using a resonant mirror bio- normal and autoimmune-prone mice, 259 sensor, 79 Nieto, M., GOmMEz, M., SANCHEZ-MaTeEos, P., FERNANDEZ, E., MAR- Lim, B.L. see WANG, J.Y. Linn, P. see Satti, M.Z. AZUELA, M., SACEDON, R., VARAS, A., GONZALEZ-AMARO, R., ZAPATA, A.G., Toripio, M.L. & SANCHEZ-Maprip, F. Expression of function- Lioté, F., BovAL-BoizarbD, B., WEILL, D., Kuntz, D. & Wautier, J.-L. ally active a4, integrin by thymic epithelial cells, 170 Blood monocyte activation in rheumatoid arthritis: increased mono- Numi, H. see SHimoso, N. cyte adhesiveness, integrin expression, and cytokine release, 13 NisHipa, M. see ARIZzONO, N. Lipsky, P. see JORGENSEN, C. Liu, L. see REINHOLD, U. Nomoto, K. see HARADA, M. Nose, M. see TANIGUCHI, Y. LORENTZEN, J.C. see HUANG, Y.H. Novick, J. see Newkirk, M.M. Lozano, R. see TorCAL, J. NuTMAN, T.B. see Cooper, P.J. Lucas, S. see KIFAYET, A. LunDAHL, J. see SKOLD, C.M. OBrien, D. see Kiecy, P.D.W. LUNDBERG, C. see EBENFELT, A. Orte, T. see NARISAWA-SAITO, M. Lunpovist, H. see EBENFELT, A. OxapA, H. see Ikai, M. Oxapa, N. see Ika, M. Macanovic, M., Smnicropi, D., SHAK, S., BAUGHMAN, S., Turru, S. & Okumura, K. see KANEKO, H. LACHMANN, P.J. The treatment of systemic lupus erythematosus OuiverrA, D.B.G. see Kiety, P.D.W. (SLE) in NZB/W F, hybrid mice; studies with recombinant murine OLorsson, K., HELLSTROM, S. & HAMMARSTROM, M.-L. Abundance of DNase and with dexamethasone, 243 intraepithelial 75 T cells in hypertrophic obstructive but not in Mackay, I.R. see Row.ey, M.J. chronically infected adenoids, 396 MANICKASINGHAM, S.P., Hitt, T.J. & Wittiams, N.A. Modulation of OLSEN, K.E., SANDGREN, O., SLETTEN, K. & WESTERMARK, P. Primary Langerhans cell phenotype, migration and maturation by agents localized amyloidosis of the eyelid: two cases of immunoglobulin known to cause herpes simplex virus reactivation in a mouse light chain-derived proteins, subtype AV respectively AVI, 362 model, 304 Omura, K. see UTSUNoMIYA, Y. MARAZUELA, M. see Nieto, M. Ortiz, A. see GONZALEZ-CUADRADO, S. 580 Author Index Osaki, T. see YONEDA, K. SALVAGGIO, A. see MARzI, M. Osman, A.A. see BORNER, H. SANCHEZ-MaprIb, F. see Nieto, M. OTTONELLO, L., Morone, P., Daprno, P. & DALLEGRI, F. Inhibitory SANCHEZ-MartEos, P. see Nieto, M. effect of salmeterol on the respiratory burst of adherent human SANDGREN, O. see OLSEN, K.E. neutrophils, 97 Sany, J. see JORGENSEN, C. Ove tette, S. see SUTMULLER, M. SARGENT, M. see BERNSTEIN, C.N. Owman, H. see Huana, Y.H. SasaBE, M. see ARiZONO, N. Oxe ius, V.-A. & Eis., M.M. Different Gm allotype amounts in human Satti, M.Z., Linp, P., VENNERVALD, B.J., SULAIMAN, S.M., DAFFALLA, intravenous immunoglobulin (IVIG) preparations; survival of for- A.A. & Gua.is, H.W. Specific immunoglobulin measurements eign Gm allotypes in immunodeficient patients, 203 related to exposure and resistance to Schistosoma mansoni infection in Sudanese canal cleaners, 45 Parez, N., Herzoc, D., Jacgz-AiGRAIn, E., Homperc, J.-C. & SavaceE, C.O.S. see Brooks, C.J. ALVAREZ, F. Study of the B cell response to cytochrome P450IID6 SCHAFER-ELINDER, L. see HUANG, Y.H. in sera from chronic hepatitis C patients, 336 SCHNAUTZ, S. see REINHOLD, U. Pastor, C. see TorcaL, J. ScHULZE-Koops, H., Lipsky, P.E., KAVANAUGH, A.F. & Davis, L.S. PaTtarroyo, M.E. see Soto, M. Persistent reduction in IL-6 mRNA in peripheral blood mononuclear Peake, P.W., GREENSTEIN, J.D., PusseLt, B.A. & CHARLESworRTH, J.A. cells of patients with rheumatoid arthritis after treatment with a The behaviour of human vitronectin in vivo: effects of complement monoclonal antibody to CD54 (ICAM-1), 190 activation, conformation and phosphorylation, 416 SESTERHENN, J. see REINHOLD, U. Pearson, J.D. see HEALY, C.M. Seymour, G.J. see YAMAZAKI, K. Perez-ATAyYDE, A. see GERWIN, N. SHAHID, F. see KirAYET, A. PERRAUT, R., CHOUTEAU, P., Mooc, C., BONNEMAINS, B. & Kieny, M.P. SHAK, S. see MACANovic, M. Immunogenicity of HIV-l,4 ; gp160 and env peptides in squirrel SHIGEHARA, K. see SHuuso, N. monkey Saimiri sciureus using alumine and experimental adjuvants, Suuuso, N., Imai, K., SHIGEHARA, K., Hinopa, Y. & Ase, S. Circulating 434 soluble intercellular adhesion molecule-1 (sICAM-1) in patients with Petrersson, E. see BASKIN, B. sarcoidosis, 549 PFREUNDSCHUH, M. see VOSWINKEL, J. Suimizu, F. see NArisAwa-Saito, M. Puipps, J.L. see Hitt, M.B. Suimojo, N., KoHNo, Y., Katsuki, T., HosHioka, A., Honma, K.., PrERARD, I. see Pottier, Y. Saito, K. & Numi, H. Diminished interferon-gamma (IFN-y) Pitz, S. see KAHALY, G. production by bacterial antigen-specific T cells in atopic patients, 62 PLaza, J.J. see GONZALEZ-CUADRADO, S. Simos, H. see DEREVIANKO, A. Portier, Y., PlERARD, I., BancLAY, A., Masson, P.L. & CouTE ier, J.-P. Sinicropt, D. see MACANovic, M. The mode of action of treatment by IgG of haemolytic anaemia SKOLD, C.M., LUNDAHL, J., HALLDEN, G., HALLGREN, M. & EKLUND, A. induced by an anti-erythrocyte monoclonal antibody, 103 Chronic smoke exposure alters the phenotype pattern and the PRAKASH, D. see Cooper, P.J. metabolic response in human alveolar macrophages, 108 PumMeEr, S. see LEELAYUwAT, C. SLETTEN, K. see OLSEN, K.E. Pusey, C.D. see Levy, J.B. Smitu, C.I.E. see BAskin, B. Pusse., B.A. see PEAKE, P.W. Song, S. see TsutsuMI, H. SONNERBORG, A. see BRosTROM, C. QIFENG, X. see KAWAKAMI, K. Soto, M., REQueNna, J.M., Quuapa, L., Gomez, L.C., Guzman, F., Quuaba, L. see Soto, M. PaTARROYO, M.E. & ALonso, C. Characterization of the antigenic Quresui, M.H. see KAWAKAMI, K. determinants of the Leishmania infantum histone H3 recognized by antibodies elicited during canine visceral leishmaniasis, 454 Raprorp, D.J. see Brooks, C.J. STEVENSON, M.M. see NEwkiRK, M.M. REICHLIN, M. see TsuZAKA, K. STRONG, P. see WANG, J.Y. Reip, K.B.M. see WANG, J.Y. SULAIMAN, S.M. see Satti, M.Z. REINHOLD, U., Liu, L., SESTERHENN, J., SCHNAUTZ, S. & ABKEN, H. The SUMICHIKA, H. see HARADA, M. CD7~ T cell subset represents the majority of IL-5-secreting cells SuTMULLER, M., Exstun, G.L., OUELLETTE, S., E.DE Heer & Bruun, within CD4~ CD45RA_ Tc ells, 555 J.A.: Non-MHC genes determine the development of lupus nephritis REKOLA, S. see BASKIN, B. in H-2 identical mouse strains, 265 RemMe, T. see JORGENSEN, C. Remick, D.G. see Cooper, P.J. TAKENOYAMA, M. see HaraDA, M. REQUENA, J.M. see Soto, M. TAKEUCHI, R. see Tsutsumi, H. RissoAN, M.C., VAN KOOTEN, C., CHOMARAT, P., GALIBERT, L., TAMADA, K. see HARADA, M. Duranpb, I., Turvocet-Besui, F., Miossec, P. & BANCHEREAU, J. TAMAKI, K. see KANDA, N. The functional CD40 antigen of fibroblasts may contribute to the TANiGuUCHI, Y., Iro, M.R., Mort, S., YONEHARA, S. & Nose, M. Role of proliferation of rheumatoid synovium, 481 macrophages in the development of arteritis in MRL strains of mice Rocca, A. see Decourrt, C. with a deficit in Fas-mediated apoptosis, 26 Roman, J. see Torcat, J. TayLor, D.W. see Cooper, P.J. Rosen, F.S. see Gerwin, N. TeEGosui, T. see ARIZONO, N. Row ey, M.J., CHEN, Q.Y., Teou, K.L., Zimmer, P.Z., Tuomi, T., TELEMO, E. see DAHLMAN-HOGLUND, A. KNow es, W.J. & Mackay, I.R. Diabetic sera react with the glutamic TEN Kate, F.J.W. see Hommes, D.W. acid decarboxylase molecule in a dimeric-oligomeric form, 323 Trou, K.L. see Row.ey, M.J. Ruiz-Orteca, M. see GONZALEZ-CUADRADO, S. Tuiru, S. see Macanovic, M. RONNELID, J. see HUANG, Y.H. THIVOLET-Besul, F. see RissoaAn, M.C. THom, G. see LEELAYUwAT, C. SACEDON, R. see Nieto, M. THORNHILL, M.H. see HEALY, C.M. Sarto, A. see KAWAKAMI, K. TiL.teE-LEBLOND, I. see VANHEE, D. Sarto, K. see KANEKO, H. TouyaMa, M. see KAWAKAMI, K. Saito, K. see SHimoso, N. TONNEL, A.-B. see VANHEE, D. Sakal, O. see UtsuNomiya, Y. TorcaL, J.,. NAVARRO-ZORRAQUINO, M., Lozano, R., Larrap, L., Sakural, M. see Ito, M. SALINAS, J.C., FERRER, J., ROMAN, J. & Pastor, C. Immune response Sainas, J.C. see Torcat, J. and in vivo production of cytokines in patients with liver hydatidosis, SALLBERG, M. see Brostrom, C. 317 Author Index Toripio, M.L. see Nieto, M. WAKABAYASHI, Y. see ISHTYAMA, T. TRABATTONI, D. see MARz1, M. WALDMANN, H. see Isaacs, J.D. TREMBLAY, A. see GRANGER, D. WALLAERT, B. see VANHEE, D. Tromper, L. see VOSWINKEL, J. Wana, J.Y., Kishore, U., Lim, B.L., Stronc, P. & Rep, K.B.M. TsucuipA, T. see KANDA, N. Interaction of human lung surfactant proteins A and D with mite TsuRUOKA, N. see IsHtyAMA, T. (Dermatophagoides pteronyssinus) allergens, 367 Tsutsumi, H., Matsupa, K., Sone, S., TAKEUCHI, R. & Cnia, S. WATANABE, K. see ISHtYAMA, T. Respiratory syncytial virus-induced cytokine production by neona- WATANABE, M. see Ito, M. tal macrophages, 442 Wautier, J.-L. see Liote, F. TsUZAKA, K., WINKLER, T.H., KALDEN, J.R. & ReICHLIN, M. Autoanti- Wel, T. see Moss, R.B. bodies to double-stranded (ds)DNA immunoprecipitate 18S riboso- WEILL, D. see Liorte, F. mal RNA by virtue of their interaction with ribosomal protein S1 WEISINGER, G. see GILHAR, A. and suppress in vitro protein synthesis, 504 WEISKE, T. see BORNER, H. Tuomi, T. see Row.ey, M.J. WESTERMARK, P. see OLSEN, K.E. Turner, A.N. see Levy, J.B. WuaAL_ey, K., Sim, R.B. & He, S. Autoimmune C1-inhibitor deficiency, TytcGat, G.N.J. see Hommes, D.W. 423 WILKINS, J. see BERNSTEIN, C.N. WILKINSON, P.C. see AL-MUGHALES, J. UcniIKAWA, R. see ARIZONO, N. Wituiams, N.A. see MANICKASINGHAM, S.P. UtsunomiyA, Y., OmuRA, K., Yokoo, T., IMASAWA, T., KAWAMURA, T., Wina, M.G. see Isaacs, J.D. Ase, A., HiRANO, K., Miraral, T., MARUYAMA, N. & Sakal, O. WINKLER, T.H. see TsuzaKA, K. Macrophage-colony stimulating factor (M-CSF) enhances protei- Wirt, C. see LEELAYuwAT, C. nuria and recruitment of macrophages into the glomerulus in experimental murine nephritis, 286 Yaaita, H. see KANEKO, H. YamapaA, M. see ARIzono, N. VAN DEVENTER, S.J.H. see Hommes, D.W. YAMAMOTO, T. see YONEDA, K. VAN KOOTEN, C. see RissoAN, M.C. YAMANASHI, Y. see NARISAWA-SaITO, M. VANDENABEELE, P. see MARCHANT, A. YAMAZAKI, K., NAKAJIMA, T., GEMMELL, E., KJELDSEN, M., SEyMourR, VANHEE, D., Mo Let, S., Gosset, P., TiLLIE-LEBLOND, I., BoITELLe, A.., G.J. & Hara, K. Biased expression of T cell receptor V(@ genes in WALLAERT, B. & TONNEL, A.-B. Expression of leucocyte—endothelial periodontitis patients, 329 adhesion molecules is limited to intercellular adhesion molecule-1 Ye, Y.-L., CHUANG, Y.-H. & CHIANG, B.-L. Jn vitro and in vivo (ICAM-1) in the lung of pneumoconiotic patients: role of tumour functional analysis of CD5~ and CDS B cells of autoimmune necrosis factor-alpha (TNF-a), 541 NZB x NZW F, mice, 253 Varas, A. see Nieto, M. Yokoo, T. see UTsuNomiya, Y. VENKATAPRASAD, N. see VORDERMEIER, H.M. YOKOYAMA, Y. see IKAI, M. VENNERVALD, B.J. see Satt1, M.Z. YONEDA, K., Osaki, T. & YAmMAmorTo, T. IL-2 signalling in T and VIGANO, A. see MArzi, M. natural killer (NK) cells associated with their class I-non-restricted VIGNOLA, A.M., CHANEZ, P., CHIAPPARA, G., MERENDINO, A., ZINNANTI, killing activity, 179 E., Bousquet, J., BELLIA, V. & BonsiGNorE, G. Release of transform- YONEHARA, S. see TANIGUCHI, Y. ing growth factor-beta (TGF-) and fibronectin by alveolar macro- YosuipA, M. see IsHtyAMA, T. phages in airway diseases, 114 YosuipA, S., Hasuimoto, S., NAKAYAMA, T., KOBAYASHI, T., KOIZUMI, ViLLa, M.L. see MArRz1, M. A. & Horie, T. Elevation of serum soluble tumour necrosis factor VORDERMEIER, H.M., VENKATAPRASAD, N., Harris, D.P. & Ivanyi, J. (TNF) receptor and IL-1 receptor antagonist levels in bronchial Increase of tuberculous infection in the organs of B cell-deficient asthma, 73 mice, 312 VOSWINKEL, J. TRUMPER, L. CARBON, G. Hopr, T., PFREUNDSCHUH, M. & ZaPATA, A.G. see Nieto, M. Gause, A. Evidence for a selected humoral immune response ZHANG, Y. see Morse, J.H. encoded by V};4 family genes in the synovial membrane of a patient Z1MMET, P.Z. see RowLey, M.J. with rheumatoid arthritis (RA), 5 ZINNANTI, E. see VIGNOLA, A.M. Subject Index a, integrins, 170 CD8, 280 abortion, 127 cell adhesion, 13 acquired angio-oedema, 475 cell surface molecules, 208 activation antigens, 208 cellular defence, 404 adenoid, 396 chemokines, 462, 518 adhesion molecule, 541 chemotaxis, 230 adhesion molecules, 190, 304 chronic bronchitis, 114 adjuvants, 434 chronic graft-versus-host disease, 265 AECA, 523 chronic hepatitis, 336 alveolar macrophage, 108, 541 class IT MHC, 304 alveolar macrophages, 114 class switching, 509 amyloid, 362 cobra venom factor, 156 ANCA, 523 coeliac disease, 344 anti-DNA antibodies, 243 colitis, 529 anti-GBM autoantibodies, 265 conjunctiva, 362 anti-GBM disease, 79 CR1 (CD35) complement receptor, 297 anti-HMG antibodies, 389 Cryptococcus neoformans, 468 anti-neutrophil cytoplasmic antibodies, 273 cyclophilin, 518 anti-nucleosome, 389 cystic fibrosis, 374 anti-P450IID6, 336 cystic fibrosis transmembrane conductance regulator, 374 anti-peptide antibodies, 568 cytokine, 120, 427, 442 anti-Thy-1, 86 cytokines, 127, 190, 230, 462, 509 antibodies, 143, 312, 389 antibody-secreting cells, 447 dexamethasone, 243 antigenic determinants, 454 dimer, 323 antigenicity, 323 DNase, 243 apoptosis, 218 dog, 454 arthritis, 280 asthma, 114 eiocosanoids, 529 atopy, 62, 67 endomysium antibodies, 344 autoantibodies, 79, 336, 475, 504 endothelial antibodies, 491 autoantibody, 323, 498 eosinophil, 55 autoantigens, 344 epithelial cells, 170, 237 autofluorescence, 108 epitope mapping, 79 autoimmune haemolytic anaemia, 103 erythema nodosum leprosum, 447 autoimmunity, 336, 389, 504 Fas, 26 B>-agonists, 97 Fas ligand, 26 8>-integrins, 160 Fe receptor, 103 B cells, 312 Fc receptors, 427 B lymphocytes, 5 fibroblast, 481 bacterial colonization, 396 fibroblasts, 518 biosensor, 79 fibronectin, 114 bronchial asthma, 73 FITC, 304 Brown-Norway rat, 280 G-CSF, 529 C1 inhibitor, 475 gel shift assay, 498 Campath, 427 gliadin antibodies, 344 canal cleaners, 45 glomerular injury, 286 carboxypeptidase, 156 glomerulonephritis, 86 CD28, 218 glucocorticoids, 91 CD30, 67 glutamic acid decarboxylase, 323 CD4* T cells, 149 Gm allotype half-lives, 203 CD4* T lymphocytes, 297 Gm allotype quantities, 203 CD40, 481 Goodpasture’s disease, 79 CDS" Bc ells, 253 gp160, 434 CD7, 555 gp41 env peptide, 434 Subject Index granuloma, 26 liver hydatidosis, 317 Graves’ ophthalmopathy, 197 long-term asymptomatics, 35 lung granuloma, 55 HCV infection, 336 lupus, 504 healthy, 62 lupus nephritis, 265 heat shock, 351 lymphocytes, 374 herpes simplex virus, 304 lymphoproliferative disease, 475 histone H3, 454 HIV-1, 35, 297 M-CSF, 26 HLA class I like molecules, 568 Mac-2, 26 HLA typing, 389 macrophage, 91, 103 hsp70, 351 macrophage-colony stimulating factor, 286 human, 410, 416 macrophages, 286, 442, 468 human intraepithelial 6 T cells, 396 major histocompatibility locus, 389 human thymus, 170 Mansoni, 45 humoral response, 454 mast cell, 55 hyper-exposed, 45 mast cell-deficient Ws/Ws rat, 55 mast cells, 149 IDDM, 323 matrix proteins, 560 IgA nephropathy, 509 mercuric chloride, 280 IgA production, 509 mesangial cell, 86 IgE, 67, 317, 367 metabolic activity, 108 IgG, 317 metabolism, 416 IgG glycosylation, 259 MHC genes, 568 IL-1, 134, 273 mite allergen, 367 IL-1 receptor antagonist, 73, 237 monkeys, 434 IL-10, 91, 253 monoclonal antibody, 86, 427 IL-12, 468 monocyte, 13 IL-2, 179 monocytes, 120 IL-3, 149 mouse infection, 312 IL-4, 143, 317 MRL/JIpr, 259 IL-6, 134, 143, 410 mucosal immune response, 534 immune complexes, 243 mucosal secretion, 404 immunity, 127, 374 multicentre Castleman’s disease, 351 immunoblotting, 491 immunochemistry, 504 naive phenotype, 208 immunodeficiency, 208 natural killer cell, 40 immunofluorescence, 568 natural killer cells, 179 immunoglobulin subclasses, 447 nematode, 55 immunoglobulin therapy, 197 neonate, 442 immunoglobulin, 103, 362, 410 nephritis, 286 immunohistochemistry, 160 neutrophil, 529 immunomorphometry, 396 neutrophil function, 404 immunotherapy, 190 neutrophils, 97, 273 in vitro translation, 504 nitric oxide, 40 integrins, 13 NOD, 259 intercellular adhesion molecule-1, 20, 286 non-MHC genes, 265 intercellular adhesion molecules, 160 NZB/W F, mice, 243 interferon-gamma, 62 interleukin, 127 oligomer, 323 intestine, 156, 160 onchocerciasis, 462 ischaemia reperfusion, 156 oral tolerance, 534 ivermectin, 462 oral ulceration, 523 IVIG, 203 Otitis media, 396 oxygen tension, 560 La antigen, 498 lambda, 362 PERB11 (MIC), 568 Langerhans cells, 304 periodontitis, 329 leprosy, 447 peripheral blood mononuclear cells, 67, 410 light chain deposition disease, 357 phagocytosis, 103 lipopolysaccharide, 91 phosphodiesterase, 97 584 Subject Index phosphorylation, 416 skin-infiltrating T cells, 555 platelet-activating factor, 143 smoking, 108 PMN, 560 soluble intercellular adhesion molecule-1, 549 pneumoconiosis, 541 soluble TNF receptor, 73 pneumonia, 120 somatic mutation, 5 PPD-spcific T cell line, 62 surfactant protein A, 367 pregnancy, 127 surfactant protein D, 367 proliferation, 481 susceptible, 45 protein tyrosine kinase, 86 synovial inflammation, 5 psoriasis, 134 systemic lupus erythematosus, 218, 253, 243 quenching, 108 T cell activation, 218 T cell apoptosis, 351 RANTES, 462 T cells, 179, 374, 534 remodelling, 114 T helper cell-dependent antibody, 35 renal interstitium, 518 T lymphocyte, 143 resistant, 45 T lymphocytes, 230, 555 respiratory burst, 97 testosterone, 410 respiratory syncytial virus, 442 TCR V8, 329 reticulin antibodies, 344 the elderly, 120 rheumatoid arthritis, 5, 13, 20, 190, 230, 427 Thy-1 molecule, 86 rheumatoid factors, 259 TNF receptors, 134 rheumatoid synovium, 481 transforming growth factor-beta, 114 ribonucleoproteins, 498 tuberculosis, 312 Ro antigen, 498 tumour necrosis factor, 91, 134, 317 RT-PCR, 67, 329 tumour necrosis factor-alpha, 20, 468, 541 type IV inhibitors, 97 sarcoidosis, 549 tyrosine phosphorylation, 179 SCID mice, 20 scleroderma, 491 Vu receptor, 5 severe combined immunodeficient mice, 253 Vk, Subgroup « chain, 357 shock, 156 varicella zoster virus, 40 sialyated proteins, 208 vasculitis, 280, 523 signal transduction, 179 visceral leishmaniasis, 454 site-directed serology, 35 vitronectin, 416 Sjégren’s syndrome, 237 VLA antigen, 13

ebook img

Clinical and Experimental Immunology 1996: Vol 106 Index PDF

9 Pages·1996·1.8 MB·English
by  
#periodicals #sim_microfilm #pub_clinical-and-experimental-immunology
Save to my drive
Quick download
Download
Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Clinical and Experimental Immunology 1996: Vol 106 Index

Author Index Ase, A. see UTSUNOMIYA, Y. CHANEZ, P. see VIGNOLA, A.M. Ase, S. see SHUUBO, N. CHARLESWORTH, J.A. see PEAKE, P.W. ABKEN, H. see REINHOLD, U. CHEN, Q.Y. see Row.ey, M.J. Apu, D. see Brooks, C.J. CHIANG, B.-L. see YE, Y.-L. AGosTonI, A. see CicarpI, M. CHIAPPARA, G. see VIGNOLA, A.M. AHLSTEDT, S. see DAHLMAN-HOGLUND, A. CuisA, S. see Tsutsumi, H. Akimoto, Y. see ISHTYAMA, T. CHoMaRAT, P. see RissoAN, M.C. At-MUGHALES, J., BLyTH, T.H., HUNTER, J.A. & WILKINSON, P.C. The CHOUTEAU, P. see PERRAUT, R. chemoattractant activity of rheumatoid synovial fluid for human CHUANG, Y.-H. see YE, Y.-L. lymphocytes is due to multiple cytokines, 230 Cicarpi, M., Beretta, A., Cocomso, M., Giorrré, D., CuGNo, M. & A.onso, C. see Soto, M. Acostoni, A. Relevance of lymphoproliferative disorders and of ALVAREZ, F. see PAREZ, N. anti-Cl inhibitor autoantibodies in acquired angio-oedema, 475 AMRAOUI, Z. see MARCHANT, A. Cuerici, M. see MArzi, M. APOSTOLAKOS, P. see NEWKIRK, M.M. Cocng, M. see Decourt, C. AriIzono, N., NisHipa, M., UcHiKAWA, R., YAMADA, M., MatsupaA, S., Cotomso, M. see Cicarpi, M. TeGcosHi, T., Kirumura, Y. & SasaBe, M. Lung granulomatous Cooper, P.J., GUDERIAN, R.H., PRAKASH, D., Remick, D.G., EsPINeL, response induced by infection with the intestinal nematode Nippo- I., NuTMAN, T.B., TAYLor, D.W. & GrirFin, G.E. RANTES in strongylus brasiliensis is suppressed in mast cell-deficient Ws/Ws rats, 55 onchocerciasis: changes with ivermectin treatment, 462 AzuMaA, M. see KANEKO, H. CosMan, D. see LEELAYUWAT, C. CourerT, I. see JORGENSEN, C. BANCHEREAU, J. see RissoAN, M.C. CouTELigrR, J.-P. see Pottier, Y. Barc ay, A. see PoTTier, Y. CucGno, M. see Cicarp1, M. Barst, R.J. see Morse, J.H. BASKIN, B., PETTERSSON, E., REKOLA, S., SmitH, C.I.E. & IsLam, K.B. Dramico, R. see DEREVIANKO, A. Studies of the molecular basis of IgA production, subclass regulation DaFFALLA, A.A. see Satti, M.Z. and class-switch recombination in IgA nephropathy patients, 509 DAHLGREN, C. see EBENFELT, A. BAUGHMAN, S. see MACANovic, M. DAHLGREN, U. see DAHLMAN-HOGLUND, A. : BELLIA, V. see VIGNOLA, A.M. DAHLMAN-HOGLUND, A., AHLSTEDT, S., HANSON, L.A., DAHLGREN, U. BENBERNOU, N. see ESNAULT, S. & Texemo, E. Different expression of IL-2 receptor a-chain on a BeretTA, A. see CICARDI, M. lamina propria T cell population and goblet cells in rats orally BERNSTEIN, C.N., SARGENT, M., GALLATIN, W.M. & Wixkins, J. (>- tolerized or sensitized to ovalbumin (OA) after colonization with integrin/intercellular adhesion molecule (ICAM) expression in the an OA-producing Escherichia coli, 534 normal human intestine, 160 DALLEGRI, F. see OTTONELLO, L. Biytu, T.H. see AL-MUGHALES, J. Dapino, P. see OTTONELLO, L. BociAn, R.C. see Moss, R.B. Davip, M. see GILHAR, A. Borre, G. see GRANGER, D. Davis, L.S. see ScHULZE-Koops, H. BoiTELLe, A. see VANHEE, D. DawkIns, R. see LEELAYUWAT, C. BoLoGna, C. see JORGENSEN, C. Decourt, C., CoGné, M. & Rocca, A. Structural peculiarities of a BONNEMAINS, B. see PERRAUT, R. truncated Vay; immunoglobulin light chain in myeloma with light BONSIGNORE, G. see VIGNOLA, A.M. chain deposition disease, 357 Bousquet, J. see VIGNOLA, A.M. Dec.t-Esposti, M.A.. see LEELAYUWAT, C. Bova.L-BoizarD, B. see Liote, F. De.iprias, C.C. see MounHous, A. Boyer, V. see MounHous, A. DerREVIANKO, A., D’amico, R. & Simms, H. Polymorphonuclear leuco- Borner, H., OSMAN, A.A., MEERGANS, TH., WEISKE, T. & Motues, TH. cyte (PMN)-derived inflammatory cytokines—regulation by oxygen Isolation of antigens recognized by coeliac disease autoantibodies tension and extracellular matrix, 560 and their use in enzyme immunoassay of endomysium and reticulin DUKHUIZEN, S. see Hommes, D.W. antibody-positive human sera, 344 Dona, Y.-J. see Moss, R.B. Brocuier, J. see JORGENSEN, C. Dusost, J.-J., PERRIER, S., AFANE, M., VIALLARD, J.-L., Roux-LOMBARD, Brooks, C.J., Kinc, W.J., RApForp, D.J., Apu, D., McGratu, M. & P., BAUDET-PoMMEL, M., BeGug, C., KEMENY, J.-L. & SAUVEZzIE, B.: Savace, C.O.S. IL-1 production by human polymorphonuclear IL-1 receptor antagonist in saliva; characterization in normal saliva leucocytes stimulated by anti-neutrophil cytoplasmic autoanti- and reduced concentration in Sjégren’s syndrome (SS), 237 bodies: relevance to systemic vasculitis, 273 DurRAnb, I. see RissoAN, M.C. Brostrom, C., SONNERBORG, A., Kim, S. & SALLBERG, M. Site-directed serology of HIV-1 subtype B infection: relation between virus specific EBENFELT, A., LUNpavist, H., DAHLGREN, C. & LUNDBERG, C. Neu- antibody levels and disease progression, 35 trophils in mucosal secretion are functionally active, 404 BruuN, J.A. see SUTMULLER, M. Eaipo, J. see GONZALEZ-CUADRADO, S. Bruyns, C. see MARCHANT, A. E1s_, M.M. see Oxe.tus, V.-A. Bustos, C. see GONZALEZ-CUADRADO, S. EKLUND, A. see SKOLD, C.M. BuURMAN, W.A. see MARCHANT, A. Exstun, G.L. see SUTMULLER, M. EsNAULT, S., BENBERNOU, N., LAVAuD, F. & GuENouNOou, M. Sponta- Canovas, F. see JORGENSEN, C. neous CD30 mRNA expression in peripheral blood mononuclear CARBON, G. see VOSWINKEL, J. cells from atopic patients with high IgE serum levels, 67 CARTWRIGHT, R.J. see Hitt, M.B. EspIneEL, I. see Cooper, P.J. CARVALHO, D. see HEALY, C.M. FATENEJAD, S. & Crart, J. Intrastructural help in diversification of CHABoT, B. see GRANGER, D. humoral autoimmune responses, | 578 Author Index FERNANDEZ, E. see Nieto, M. Hearty, C.M., CarRvALHO, D., PEARSON, J.D. & THORNHILL, M.H. Ferrer, J. see Torcat, J. Raised anti-endothelial cell autoantibodies (AECA), but not anti- Frers, W. see MARCHANT, A. neutrophil cytoplasmic autoantibodies (ANCA), in recurrent oral Fiscuer, E. see Mounous, A. ulceration: modulation of AECA binding by tumour necrosis factor- FLAasTer, E. see Morse, J.H. alpha (TNF-a) and interferon-gamma (IFN-7), 523 Fortino, M. see Morse, J.H. HELLsTROM, S. see OLOFSSON, K. Fournier, M.-J. see NewkirK, M.M. Herzoa, D. see PAREz, N. Friepricn, C. see Gerwin, N. Hitt, M.B., Puipps, J.L., CARTwriGHt, R.J., MILFORD WARD, A., Fritz_er, M.J. see Morse, J.H. Greaves, M. & HuGues, P. Antibodies to membranes of endothelial FrosteGArD, J. see HUANG, Y.H. cells and fibroblasts in scleroderma, 491 Fukucul, K. see IsHtyAMa, T. Hitt, T.J. see MANICKASINGHAM, S.P. Hinopa, Y. see SHuuso, N. GALIBERT, L. see Rissoan, M.C. Hirano, K. see UTsuNomiya, Y. GALLATIN, W.M. see BERNSTEIN, C.N. HOoLLINGswortH, P. see LEELAYUWAT, C. GARDNER, P. see Moss, R.B. HomeeraG, J.-C. see PAREz, N. HomMEL, G. see KAHALY, G. Gause, A. see VOSWINKEL, J. GEMMELL, E. see YAMAZAKI, K. Hommes, D.W., MEENAN, J., DukHuizeN, S., TEN KATE, F.J.W., Tytocat, G.N.J. & VAN DEVENTER, S.J.H. Efficacy of recombinant GENDRON, M. see GRANGER, D. granulocyte colony-stimulating factor (rhG-CSF) in experimental Georce, A.J.T. see Levy, J.B. Gerwin, N., Frieprich, C., Perez-Ataype, A., Rosen, F.S. & colitis, 529 GuTieERREz-Ramos, J.C. Multiple antigens are altered on T and B Honma, K. see SHimojo, N. lymphocytes from peripheral blood and spleen of patients with Hopr, T. see VOSWINKEL, J. Wiskott—Aldrich syndrome, 208 Horie, T. see Gon, Y. Gua.is, H.W. see Sati, M.Z. Horie, T. see Yosuipa, S. Gityar, A. Davin, M., Kauisu, R.S. & Weisincer, G. Jn vivo effects of Hosui0KA, A. see SHimojo, N. cytokines on psoriatic skin grafted on nude mice: involvement of the Hsu, Y.-P. see Moss, R.B. tumour necrosis factor (TNF) receptor, 134 Huanc, Y.H., SCHAFER-ELINDER, L., OwMAN, H., LoRENTZEN, J.C., Giorrre, D. see Cicarpi, M. RONNELID, J. & FrosteGArb, J. Induction of IL-4 by platelet- GoLpMAN, M. see MARCHANT, A. activating factor, 143 Gomez, L.C. see Soto, M. Huaues, P. see Hitt, M.B. Gon, Y., Hasurmoro, S., Hayasui, S., Koura, T., Matsumoto, K. & Hunter, J.A. see AL-MUGHALEs, J. Horie, T. Lower serum concentrations of cytokines in elderly Hussaln, R. see KiFAYET, A. patients with pneumonia and the impaired production of cytokines by peripheral blood monocytes in the elderly, 120 Ikal, M., Iron, M., Jon, T., YoKoyAMA, Y., OKADA, N. & Oxapba, H. GoNZALEZ-AMARO, R. see Nieto, M. Complement plays an essential role in shock following intestinal GoNZALEZ-CUADRADO, S., Bustos, C., Ruiz~-Orteca, M., Ortiz, A., ischaemia in rats, 156 Guuarro, C., Praza, J.J. & Ecipo, J. Expression of leucocyte Imal, K. see SHuuso, N. chemoattractants by interstitial renal fibroblasts: up-regulation by IMASAWA, T. see UTSUNOoMIYA, Y. drugs associated with interstitial fibrosis, 518 Isaacs, J.D., Winc, M.G., GREENwoop, J.D., HAZLEMAN, B.L., HALE, Gossett, P. see VANHEE, D. G. & WALDMANN, H. A therapeutic human IgG4 monoclonal anti- Grancer, D., GENDRON, M., TremBLAy, A., CHABOT, B., MENARD, body that depletes target cells in humans, 427 H.A. & Boire, G. RNA-labelled Ro and La ribonucleoprotein IsHIYAMA, T., Korke, M., Akimoto, Y., Fukucui, K., WATANABE, K.., complexes reassembled in vitro; characterization by gel shift analy- YosHipaA, M., WAKABAYASHI, Y. & TsuRUOKA, N. Heat shock- sis, 498 enhanced T cell apoptosis with heat shock protein 70 on T cell Greaves, M. see Hitt, M.B. surface in multicentric Castleman’s disease, 351 GREENSTEIN, J.D. see PEAKE, P.W. IsLaM, K.B. see BASKIN, B. Greenwoop, J.D. see Isaacs, J.D. Ito, M.R. see TANIGUCHI, Y. Grirrin, G.E. see Cooper, P.J. Ito, M., WATANABE, M., Kamiya, H. & Sakurai, M. Inhibition of GuDERIAN, R.H. see Cooper, P.J. natural killer (NK) cell activity against varicella-zoster virus (VZV)- GuENOUNOU, M. see EsNAULT, S. infected fibroblasts and lymphocyte activation in response to VZV GuEYDAN, C. see MARCHANT, A. antigen by nitric oxide-releasing agents, 40 Guuarro, C. see GONZALEZ-CUADRADO, S. Ito, O. see HARADA, M. GUTIERREZ-Ramos, J.C. see Gerwin, N. Iron, M. see Ika1, M. Guzman, F. see Soto, M. Ivanyl, J. see VORDERMEIER, H.M. Gomez, M. see Nieto, M. Hate, G. see Isaacs, J.D. Jacgz-AlIGRAIN, E. see PAREz, N. HALLDEN, G. see SKOLD, C.M. Jou, T. see Ikai, M. JORGENSEN, C., Couret, I., CANovas, F., BoLoGNa, C., Brocuier, J., HALLGREN, M. see SKOLD, C.M. Reme, T., Lipsky, P. & Sany, J. Mononuclear cell retention in HAMANO, S. see HARADA, M. rheumatoid synovial tissue engrafted in severe combined immuno- HAMMARSTROM, M.-L. see OLorsson, K. deficient (SCID) mice is up-regulated by tumour necrosis factor- Hanson, L.A. see DAHLMAN-HOGLUND, A. alpha (TNF-a) and mediated through intercellular adhesion mole- Hara, K. see YAMAZAKI, K. cule-1 (ICAM-1), 20 HaraDA, M., SumicuikA, H., HAMANo, S., Ito, O., TAMADA, K., TAKENOYAMA, M., Kimura, G. & Nomoto, K. IL-3 derived from CD4" Tc ells is essential for the in vitro expansion of mast cells from KaHaLy, G., Pitz, S., MOLLER-FoRELL, W. & HomMMEL, G. Randomized the normal adult mouse spleen, 149 trial of intravenous immunoglobulins versus prednisolone in Graves’ Harris, D.P. see VorDERMEIER, H.M. ophthalmopathy, 197 Hasuimorto, H. see KANEKO, H. KALDEN, J.R. see TsuZAKA, K. Hasuimoro, S. see Gon, Y. KALisH, R.S. see GILHAR, A. Hasuimoro, S. see YOsHIDA, S. Kamiya, H. see Ito, M. Hayasul, S. see Gon, Y. KanpbaA, N., Tsucuipa, T. & TAMAKI, K. Testosterone inhibits immu- HAZLEMAN, B.L. see Isaacs, J.D. noglobulin production by human peripheral blood mononuclear He, S. see WHALEY, K. cells, 410 Author Index 579 KANEKO, H., Sarto, K., HasHimoto, H., YaGiTA, H., OkumurRA, K. & MARCHANT, A. AMRAOuI, Z. GUEYDAN, C., BRuyNns, C., LE Morne, O. Azuma, M. Preferential elimination of CD28" T cells in systemic VANDENABEELE, P., Fiers, W., BUURMAN, W.A. & GOLDMAN, M. lupus erythematosus (SLE) and the relation with activation-induced Methylprednisolone differentially regulates IL-10 and tumour necro- apoptosis, 218 sis factor (TNF) production during murine endotoxaemia, 91 KATSUKI, T. see SHIMoJO, N. MaruyAaMA, N. see UtTsuNomiya, Y. KAUFMAN, J. see LEELAYUWAT, C. Marzi, M., VIGANO, A., TRABATTONI, D., ViLLA, M.L., SALVAGGIO, A.., KAVANAUGH, A.F. see SCHULZE-Koops, H. Cuerici, E. & Cierici, M. Characterization of type 1 and type 2 KAWAKAMI, K., QIFENG, X., TOHYAMA, M., QuresHI, M.H. & Sarto, A. cytokine production profile in physiologic and pathologic human Contribution of tumour necrosis factor-alpha (TNF-a) in host pregnancy, 127 defence mechanism against Cryptococcus neoformans, 468 Masson, P.L. see Pottier, Y. KAWAMURA, T. see UTSUNOMIYA, Y. MatsuDA, K. see TsutTsuMI, H. KAZATCHKINE, M.D. see Mounous, A. Matsupa, S. see ARIZzONO, N. Kemna, M. see Moss, R.B. Matsumoto, K. see Gon, Y. Kie.y, P.D.W., Ovprien, D. & Oxiverra, D.B.G. Anti-CD8 treatment McGrath, M. see Brooks, C.J. reduces the severity of inflammatory arthritis, but not vasculitis, in MEENAN, J. see Hommes, D.W. mercuric chloride-induced autoimmunity, 280 MEERGANS, TH. see BORNER, H. Kreny, M.P. see PERRAUT, R. MENARD, H.A. see GRANGER, D. KirayYet, A., SHAHID, F., Lucas, S. & Hussain, R. Erythema nodosum MERENDINO, A. see VIGNOLA, A.M. leprosum is associated with up-regulation of polyclonal IgG1 anti- MILFORD WARD, A. see Hitt, M.B. body synthesis, 447 Miossec, P. see Rissoan, M.C. Kin, S. see BRostrOm, C. Miraral, T. see UTsuNomiya, Y. Kimura, G. see HARADA, M. MoLET, S. see VANHEE, D. KinG, W.J. see Brooks, C.J. Moos, C. see PERRAUT, R. KIsHoRE, U. see WANG, J.Y. Monrl, S. see TANIGUCHI, Y. KiTuMURA, Y. see ARIZONO, N. Morioka, T. see NARISAWA-SaITO, M. KJELDSEN, M. see YAMAZAKI, K. Morone, P. see OTTONELLO, L. KNow Les, W.J. see Rowey, M.J. Morse, J.H., BAarst, R.J., Fotiwo, M., ZHANG, Y., FLASTER, E. & KosAYASHI, T. see YOSHIDA, S. Fritz_er, M.J. Primary pulmonary hypertension: immunogenetic Kouno, Y. see SHimojo, N. response to high-mobility group (HMG) proteins and histone, 389 Koike, M. see IsHtyAMA, T. Moss, R.B., BociAn, R.C., Hsu, Y.-P., Done, Y.-J., KEMNA, M., WEI, Koizumi, A. see YOSHIDA, S. T. & Garpner, P. Reduced IL-10 secretion by CD4* T lymphocytes Koura, T. see Gon, Y. expressing mutant cystic fibrosis transmembrane conductance reg- Kuntz, D. see Lioté, F. ulator (CFTR), 374 Motes, TH. see BORNER, H. Mounous, A., Deviprias, C.C., Fischer, E., Boyer, V. & KAZATCH- LACHMANN, P.J. see MAcANovic, M. KINE, M.D. Ligation of CR1 (C3b receptor, CD35) on CD4* T LACHMANN, P.J. The in vivo destruction of antigen a tool for probing lymphocytes enhances viral replication in HIV-infected cells, 297 and modulating an autoimmune response, 187 MULLBERG, J. see LEELAYUWAT, C. LarRRAD, L. see Torcat, J. MULLER-FoRELL, W. see KAHALY, G. LAvAuD, F. see ESNAULT, S. LE MOINE, O. see MARCHANT, A. NAKAJIMA, T. see YAMAZAKI, K. LEELAYUWAT, C., HOLLINGSWoRTH, P., PUMMER, S., LERTMEMONG- NAKAYAMA, T. see YOSHIDA, S. KOLCHAI, G., THOM, G., MULLBERG, J., Witt, C., KAuFMan, J., Dec.i-Esposti, M.A.., CosMAN, D. & DAwkins, R. Antibody reac- NARISAWA-SAITO, M., YAMANASHI, Y. Morioka, T., Orre, T. & SHimizu, F. Thy-1 molecule associates with protein tyrosine kinase(s) in rat tivity profiles following immunization with diverse peptides of the mesangial cells, 86 PERBI11 (MIC) family, 568 NAVARRO-ZORRAQUINO, M. see TorCAL, J. LERTMEMONGKOLCHAI, G. see LEELAYUWAT, C. Levy, J.B., TURNER, A.N., GeorGce, A.J.T. & Pusey, C.D. Epitope Newkirk, M.M., Novick, J., STEVENSON, M.M., Fournier, M.-J. & AposToLakos, P. : Differential clearance of glycoforms of IgG in analysis of the Goodpasture antigen using a resonant mirror bio- normal and autoimmune-prone mice, 259 sensor, 79 Nieto, M., GOmMEz, M., SANCHEZ-MaTeEos, P., FERNANDEZ, E., MAR- Lim, B.L. see WANG, J.Y. Linn, P. see Satti, M.Z. AZUELA, M., SACEDON, R., VARAS, A., GONZALEZ-AMARO, R., ZAPATA, A.G., Toripio, M.L. & SANCHEZ-Maprip, F. Expression of function- Lioté, F., BovAL-BoizarbD, B., WEILL, D., Kuntz, D. & Wautier, J.-L. ally active a4, integrin by thymic epithelial cells, 170 Blood monocyte activation in rheumatoid arthritis: increased mono- Numi, H. see SHimoso, N. cyte adhesiveness, integrin expression, and cytokine release, 13 NisHipa, M. see ARIZzONO, N. Lipsky, P. see JORGENSEN, C. Liu, L. see REINHOLD, U. Nomoto, K. see HARADA, M. Nose, M. see TANIGUCHI, Y. LORENTZEN, J.C. see HUANG, Y.H. Novick, J. see Newkirk, M.M. Lozano, R. see TorCAL, J. NuTMAN, T.B. see Cooper, P.J. Lucas, S. see KIFAYET, A. LunDAHL, J. see SKOLD, C.M. OBrien, D. see Kiecy, P.D.W. LUNDBERG, C. see EBENFELT, A. Orte, T. see NARISAWA-SAITO, M. Lunpovist, H. see EBENFELT, A. OxapA, H. see Ikai, M. Oxapa, N. see Ika, M. Macanovic, M., Smnicropi, D., SHAK, S., BAUGHMAN, S., Turru, S. & Okumura, K. see KANEKO, H. LACHMANN, P.J. The treatment of systemic lupus erythematosus OuiverrA, D.B.G. see Kiety, P.D.W. (SLE) in NZB/W F, hybrid mice; studies with recombinant murine OLorsson, K., HELLSTROM, S. & HAMMARSTROM, M.-L. Abundance of DNase and with dexamethasone, 243 intraepithelial 75 T cells in hypertrophic obstructive but not in Mackay, I.R. see Row.ey, M.J. chronically infected adenoids, 396 MANICKASINGHAM, S.P., Hitt, T.J. & Wittiams, N.A. Modulation of OLSEN, K.E., SANDGREN, O., SLETTEN, K. & WESTERMARK, P. Primary Langerhans cell phenotype, migration and maturation by agents localized amyloidosis of the eyelid: two cases of immunoglobulin known to cause herpes simplex virus reactivation in a mouse light chain-derived proteins, subtype AV respectively AVI, 362 model, 304 Omura, K. see UTSUNoMIYA, Y. MARAZUELA, M. see Nieto, M. Ortiz, A. see GONZALEZ-CUADRADO, S. 580 Author Index Osaki, T. see YONEDA, K. SALVAGGIO, A. see MARzI, M. Osman, A.A. see BORNER, H. SANCHEZ-MaprIb, F. see Nieto, M. OTTONELLO, L., Morone, P., Daprno, P. & DALLEGRI, F. Inhibitory SANCHEZ-MartEos, P. see Nieto, M. effect of salmeterol on the respiratory burst of adherent human SANDGREN, O. see OLSEN, K.E. neutrophils, 97 Sany, J. see JORGENSEN, C. Ove tette, S. see SUTMULLER, M. SARGENT, M. see BERNSTEIN, C.N. Owman, H. see Huana, Y.H. SasaBE, M. see ARiZONO, N. Oxe ius, V.-A. & Eis., M.M. Different Gm allotype amounts in human Satti, M.Z., Linp, P., VENNERVALD, B.J., SULAIMAN, S.M., DAFFALLA, intravenous immunoglobulin (IVIG) preparations; survival of for- A.A. & Gua.is, H.W. Specific immunoglobulin measurements eign Gm allotypes in immunodeficient patients, 203 related to exposure and resistance to Schistosoma mansoni infection in Sudanese canal cleaners, 45 Parez, N., Herzoc, D., Jacgz-AiGRAIn, E., Homperc, J.-C. & SavaceE, C.O.S. see Brooks, C.J. ALVAREZ, F. Study of the B cell response to cytochrome P450IID6 SCHAFER-ELINDER, L. see HUANG, Y.H. in sera from chronic hepatitis C patients, 336 SCHNAUTZ, S. see REINHOLD, U. Pastor, C. see TorcaL, J. ScHULZE-Koops, H., Lipsky, P.E., KAVANAUGH, A.F. & Davis, L.S. PaTtarroyo, M.E. see Soto, M. Persistent reduction in IL-6 mRNA in peripheral blood mononuclear Peake, P.W., GREENSTEIN, J.D., PusseLt, B.A. & CHARLESworRTH, J.A. cells of patients with rheumatoid arthritis after treatment with a The behaviour of human vitronectin in vivo: effects of complement monoclonal antibody to CD54 (ICAM-1), 190 activation, conformation and phosphorylation, 416 SESTERHENN, J. see REINHOLD, U. Pearson, J.D. see HEALY, C.M. Seymour, G.J. see YAMAZAKI, K. Perez-ATAyYDE, A. see GERWIN, N. SHAHID, F. see KirAYET, A. PERRAUT, R., CHOUTEAU, P., Mooc, C., BONNEMAINS, B. & Kieny, M.P. SHAK, S. see MACANovic, M. Immunogenicity of HIV-l,4 ; gp160 and env peptides in squirrel SHIGEHARA, K. see SHuuso, N. monkey Saimiri sciureus using alumine and experimental adjuvants, Suuuso, N., Imai, K., SHIGEHARA, K., Hinopa, Y. & Ase, S. Circulating 434 soluble intercellular adhesion molecule-1 (sICAM-1) in patients with Petrersson, E. see BASKIN, B. sarcoidosis, 549 PFREUNDSCHUH, M. see VOSWINKEL, J. Suimizu, F. see NArisAwa-Saito, M. Puipps, J.L. see Hitt, M.B. Suimojo, N., KoHNo, Y., Katsuki, T., HosHioka, A., Honma, K.., PrERARD, I. see Pottier, Y. Saito, K. & Numi, H. Diminished interferon-gamma (IFN-y) Pitz, S. see KAHALY, G. production by bacterial antigen-specific T cells in atopic patients, 62 PLaza, J.J. see GONZALEZ-CUADRADO, S. Simos, H. see DEREVIANKO, A. Portier, Y., PlERARD, I., BancLAY, A., Masson, P.L. & CouTE ier, J.-P. Sinicropt, D. see MACANovic, M. The mode of action of treatment by IgG of haemolytic anaemia SKOLD, C.M., LUNDAHL, J., HALLDEN, G., HALLGREN, M. & EKLUND, A. induced by an anti-erythrocyte monoclonal antibody, 103 Chronic smoke exposure alters the phenotype pattern and the PRAKASH, D. see Cooper, P.J. metabolic response in human alveolar macrophages, 108 PumMeEr, S. see LEELAYUwAT, C. SLETTEN, K. see OLSEN, K.E. Pusey, C.D. see Levy, J.B. Smitu, C.I.E. see BAskin, B. Pusse., B.A. see PEAKE, P.W. Song, S. see TsutsuMI, H. SONNERBORG, A. see BRosTROM, C. QIFENG, X. see KAWAKAMI, K. Soto, M., REQueNna, J.M., Quuapa, L., Gomez, L.C., Guzman, F., Quuaba, L. see Soto, M. PaTARROYO, M.E. & ALonso, C. Characterization of the antigenic Quresui, M.H. see KAWAKAMI, K. determinants of the Leishmania infantum histone H3 recognized by antibodies elicited during canine visceral leishmaniasis, 454 Raprorp, D.J. see Brooks, C.J. STEVENSON, M.M. see NEwkiRK, M.M. REICHLIN, M. see TsuZAKA, K. STRONG, P. see WANG, J.Y. Reip, K.B.M. see WANG, J.Y. SULAIMAN, S.M. see Satti, M.Z. REINHOLD, U., Liu, L., SESTERHENN, J., SCHNAUTZ, S. & ABKEN, H. The SUMICHIKA, H. see HARADA, M. CD7~ T cell subset represents the majority of IL-5-secreting cells SuTMULLER, M., Exstun, G.L., OUELLETTE, S., E.DE Heer & Bruun, within CD4~ CD45RA_ Tc ells, 555 J.A.: Non-MHC genes determine the development of lupus nephritis REKOLA, S. see BASKIN, B. in H-2 identical mouse strains, 265 RemMe, T. see JORGENSEN, C. Remick, D.G. see Cooper, P.J. TAKENOYAMA, M. see HaraDA, M. REQUENA, J.M. see Soto, M. TAKEUCHI, R. see Tsutsumi, H. RissoAN, M.C., VAN KOOTEN, C., CHOMARAT, P., GALIBERT, L., TAMADA, K. see HARADA, M. Duranpb, I., Turvocet-Besui, F., Miossec, P. & BANCHEREAU, J. TAMAKI, K. see KANDA, N. The functional CD40 antigen of fibroblasts may contribute to the TANiGuUCHI, Y., Iro, M.R., Mort, S., YONEHARA, S. & Nose, M. Role of proliferation of rheumatoid synovium, 481 macrophages in the development of arteritis in MRL strains of mice Rocca, A. see Decourrt, C. with a deficit in Fas-mediated apoptosis, 26 Roman, J. see Torcat, J. TayLor, D.W. see Cooper, P.J. Rosen, F.S. see Gerwin, N. TeEGosui, T. see ARIZONO, N. Row ey, M.J., CHEN, Q.Y., Teou, K.L., Zimmer, P.Z., Tuomi, T., TELEMO, E. see DAHLMAN-HOGLUND, A. KNow es, W.J. & Mackay, I.R. Diabetic sera react with the glutamic TEN Kate, F.J.W. see Hommes, D.W. acid decarboxylase molecule in a dimeric-oligomeric form, 323 Trou, K.L. see Row.ey, M.J. Ruiz-Orteca, M. see GONZALEZ-CUADRADO, S. Tuiru, S. see Macanovic, M. RONNELID, J. see HUANG, Y.H. THIVOLET-Besul, F. see RissoaAn, M.C. THom, G. see LEELAYUwAT, C. SACEDON, R. see Nieto, M. THORNHILL, M.H. see HEALY, C.M. Sarto, A. see KAWAKAMI, K. TiL.teE-LEBLOND, I. see VANHEE, D. Sarto, K. see KANEKO, H. TouyaMa, M. see KAWAKAMI, K. Saito, K. see SHimoso, N. TONNEL, A.-B. see VANHEE, D. Sakal, O. see UtsuNomiya, Y. TorcaL, J.,. NAVARRO-ZORRAQUINO, M., Lozano, R., Larrap, L., Sakural, M. see Ito, M. SALINAS, J.C., FERRER, J., ROMAN, J. & Pastor, C. Immune response Sainas, J.C. see Torcat, J. and in vivo production of cytokines in patients with liver hydatidosis, SALLBERG, M. see Brostrom, C. 317 Author Index Toripio, M.L. see Nieto, M. WAKABAYASHI, Y. see ISHTYAMA, T. TRABATTONI, D. see MARz1, M. WALDMANN, H. see Isaacs, J.D. TREMBLAY, A. see GRANGER, D. WALLAERT, B. see VANHEE, D. Tromper, L. see VOSWINKEL, J. Wana, J.Y., Kishore, U., Lim, B.L., Stronc, P. & Rep, K.B.M. TsucuipA, T. see KANDA, N. Interaction of human lung surfactant proteins A and D with mite TsuRUOKA, N. see IsHtyAMA, T. (Dermatophagoides pteronyssinus) allergens, 367 Tsutsumi, H., Matsupa, K., Sone, S., TAKEUCHI, R. & Cnia, S. WATANABE, K. see ISHtYAMA, T. Respiratory syncytial virus-induced cytokine production by neona- WATANABE, M. see Ito, M. tal macrophages, 442 Wautier, J.-L. see Liote, F. TsUZAKA, K., WINKLER, T.H., KALDEN, J.R. & ReICHLIN, M. Autoanti- Wel, T. see Moss, R.B. bodies to double-stranded (ds)DNA immunoprecipitate 18S riboso- WEILL, D. see Liorte, F. mal RNA by virtue of their interaction with ribosomal protein S1 WEISINGER, G. see GILHAR, A. and suppress in vitro protein synthesis, 504 WEISKE, T. see BORNER, H. Tuomi, T. see Row.ey, M.J. WESTERMARK, P. see OLSEN, K.E. Turner, A.N. see Levy, J.B. WuaAL_ey, K., Sim, R.B. & He, S. Autoimmune C1-inhibitor deficiency, TytcGat, G.N.J. see Hommes, D.W. 423 WILKINS, J. see BERNSTEIN, C.N. WILKINSON, P.C. see AL-MUGHALES, J. UcniIKAWA, R. see ARIZONO, N. Wituiams, N.A. see MANICKASINGHAM, S.P. UtsunomiyA, Y., OmuRA, K., Yokoo, T., IMASAWA, T., KAWAMURA, T., Wina, M.G. see Isaacs, J.D. Ase, A., HiRANO, K., Miraral, T., MARUYAMA, N. & Sakal, O. WINKLER, T.H. see TsuzaKA, K. Macrophage-colony stimulating factor (M-CSF) enhances protei- Wirt, C. see LEELAYuwAT, C. nuria and recruitment of macrophages into the glomerulus in experimental murine nephritis, 286 Yaaita, H. see KANEKO, H. YamapaA, M. see ARIzono, N. VAN DEVENTER, S.J.H. see Hommes, D.W. YAMAMOTO, T. see YONEDA, K. VAN KOOTEN, C. see RissoAN, M.C. YAMANASHI, Y. see NARISAWA-SaITO, M. VANDENABEELE, P. see MARCHANT, A. YAMAZAKI, K., NAKAJIMA, T., GEMMELL, E., KJELDSEN, M., SEyMourR, VANHEE, D., Mo Let, S., Gosset, P., TiLLIE-LEBLOND, I., BoITELLe, A.., G.J. & Hara, K. Biased expression of T cell receptor V(@ genes in WALLAERT, B. & TONNEL, A.-B. Expression of leucocyte—endothelial periodontitis patients, 329 adhesion molecules is limited to intercellular adhesion molecule-1 Ye, Y.-L., CHUANG, Y.-H. & CHIANG, B.-L. Jn vitro and in vivo (ICAM-1) in the lung of pneumoconiotic patients: role of tumour functional analysis of CD5~ and CDS B cells of autoimmune necrosis factor-alpha (TNF-a), 541 NZB x NZW F, mice, 253 Varas, A. see Nieto, M. Yokoo, T. see UTsuNomiya, Y. VENKATAPRASAD, N. see VORDERMEIER, H.M. YOKOYAMA, Y. see IKAI, M. VENNERVALD, B.J. see Satt1, M.Z. YONEDA, K., Osaki, T. & YAmMAmorTo, T. IL-2 signalling in T and VIGANO, A. see MArzi, M. natural killer (NK) cells associated with their class I-non-restricted VIGNOLA, A.M., CHANEZ, P., CHIAPPARA, G., MERENDINO, A., ZINNANTI, killing activity, 179 E., Bousquet, J., BELLIA, V. & BonsiGNorE, G. Release of transform- YONEHARA, S. see TANIGUCHI, Y. ing growth factor-beta (TGF-) and fibronectin by alveolar macro- YosuipA, M. see IsHtyAMA, T. phages in airway diseases, 114 YosuipA, S., Hasuimoto, S., NAKAYAMA, T., KOBAYASHI, T., KOIZUMI, ViLLa, M.L. see MArRz1, M. A. & Horie, T. Elevation of serum soluble tumour necrosis factor VORDERMEIER, H.M., VENKATAPRASAD, N., Harris, D.P. & Ivanyi, J. (TNF) receptor and IL-1 receptor antagonist levels in bronchial Increase of tuberculous infection in the organs of B cell-deficient asthma, 73 mice, 312 VOSWINKEL, J. TRUMPER, L. CARBON, G. Hopr, T., PFREUNDSCHUH, M. & ZaPATA, A.G. see Nieto, M. Gause, A. Evidence for a selected humoral immune response ZHANG, Y. see Morse, J.H. encoded by V};4 family genes in the synovial membrane of a patient Z1MMET, P.Z. see RowLey, M.J. with rheumatoid arthritis (RA), 5 ZINNANTI, E. see VIGNOLA, A.M. Subject Index a, integrins, 170 CD8, 280 abortion, 127 cell adhesion, 13 acquired angio-oedema, 475 cell surface molecules, 208 activation antigens, 208 cellular defence, 404 adenoid, 396 chemokines, 462, 518 adhesion molecule, 541 chemotaxis, 230 adhesion molecules, 190, 304 chronic bronchitis, 114 adjuvants, 434 chronic graft-versus-host disease, 265 AECA, 523 chronic hepatitis, 336 alveolar macrophage, 108, 541 class IT MHC, 304 alveolar macrophages, 114 class switching, 509 amyloid, 362 cobra venom factor, 156 ANCA, 523 coeliac disease, 344 anti-DNA antibodies, 243 colitis, 529 anti-GBM autoantibodies, 265 conjunctiva, 362 anti-GBM disease, 79 CR1 (CD35) complement receptor, 297 anti-HMG antibodies, 389 Cryptococcus neoformans, 468 anti-neutrophil cytoplasmic antibodies, 273 cyclophilin, 518 anti-nucleosome, 389 cystic fibrosis, 374 anti-P450IID6, 336 cystic fibrosis transmembrane conductance regulator, 374 anti-peptide antibodies, 568 cytokine, 120, 427, 442 anti-Thy-1, 86 cytokines, 127, 190, 230, 462, 509 antibodies, 143, 312, 389 antibody-secreting cells, 447 dexamethasone, 243 antigenic determinants, 454 dimer, 323 antigenicity, 323 DNase, 243 apoptosis, 218 dog, 454 arthritis, 280 asthma, 114 eiocosanoids, 529 atopy, 62, 67 endomysium antibodies, 344 autoantibodies, 79, 336, 475, 504 endothelial antibodies, 491 autoantibody, 323, 498 eosinophil, 55 autoantigens, 344 epithelial cells, 170, 237 autofluorescence, 108 epitope mapping, 79 autoimmune haemolytic anaemia, 103 erythema nodosum leprosum, 447 autoimmunity, 336, 389, 504 Fas, 26 B>-agonists, 97 Fas ligand, 26 8>-integrins, 160 Fe receptor, 103 B cells, 312 Fc receptors, 427 B lymphocytes, 5 fibroblast, 481 bacterial colonization, 396 fibroblasts, 518 biosensor, 79 fibronectin, 114 bronchial asthma, 73 FITC, 304 Brown-Norway rat, 280 G-CSF, 529 C1 inhibitor, 475 gel shift assay, 498 Campath, 427 gliadin antibodies, 344 canal cleaners, 45 glomerular injury, 286 carboxypeptidase, 156 glomerulonephritis, 86 CD28, 218 glucocorticoids, 91 CD30, 67 glutamic acid decarboxylase, 323 CD4* T cells, 149 Gm allotype half-lives, 203 CD4* T lymphocytes, 297 Gm allotype quantities, 203 CD40, 481 Goodpasture’s disease, 79 CDS" Bc ells, 253 gp160, 434 CD7, 555 gp41 env peptide, 434 Subject Index granuloma, 26 liver hydatidosis, 317 Graves’ ophthalmopathy, 197 long-term asymptomatics, 35 lung granuloma, 55 HCV infection, 336 lupus, 504 healthy, 62 lupus nephritis, 265 heat shock, 351 lymphocytes, 374 herpes simplex virus, 304 lymphoproliferative disease, 475 histone H3, 454 HIV-1, 35, 297 M-CSF, 26 HLA class I like molecules, 568 Mac-2, 26 HLA typing, 389 macrophage, 91, 103 hsp70, 351 macrophage-colony stimulating factor, 286 human, 410, 416 macrophages, 286, 442, 468 human intraepithelial 6 T cells, 396 major histocompatibility locus, 389 human thymus, 170 Mansoni, 45 humoral response, 454 mast cell, 55 hyper-exposed, 45 mast cell-deficient Ws/Ws rat, 55 mast cells, 149 IDDM, 323 matrix proteins, 560 IgA nephropathy, 509 mercuric chloride, 280 IgA production, 509 mesangial cell, 86 IgE, 67, 317, 367 metabolic activity, 108 IgG, 317 metabolism, 416 IgG glycosylation, 259 MHC genes, 568 IL-1, 134, 273 mite allergen, 367 IL-1 receptor antagonist, 73, 237 monkeys, 434 IL-10, 91, 253 monoclonal antibody, 86, 427 IL-12, 468 monocyte, 13 IL-2, 179 monocytes, 120 IL-3, 149 mouse infection, 312 IL-4, 143, 317 MRL/JIpr, 259 IL-6, 134, 143, 410 mucosal immune response, 534 immune complexes, 243 mucosal secretion, 404 immunity, 127, 374 multicentre Castleman’s disease, 351 immunoblotting, 491 immunochemistry, 504 naive phenotype, 208 immunodeficiency, 208 natural killer cell, 40 immunofluorescence, 568 natural killer cells, 179 immunoglobulin subclasses, 447 nematode, 55 immunoglobulin therapy, 197 neonate, 442 immunoglobulin, 103, 362, 410 nephritis, 286 immunohistochemistry, 160 neutrophil, 529 immunomorphometry, 396 neutrophil function, 404 immunotherapy, 190 neutrophils, 97, 273 in vitro translation, 504 nitric oxide, 40 integrins, 13 NOD, 259 intercellular adhesion molecule-1, 20, 286 non-MHC genes, 265 intercellular adhesion molecules, 160 NZB/W F, mice, 243 interferon-gamma, 62 interleukin, 127 oligomer, 323 intestine, 156, 160 onchocerciasis, 462 ischaemia reperfusion, 156 oral tolerance, 534 ivermectin, 462 oral ulceration, 523 IVIG, 203 Otitis media, 396 oxygen tension, 560 La antigen, 498 lambda, 362 PERB11 (MIC), 568 Langerhans cells, 304 periodontitis, 329 leprosy, 447 peripheral blood mononuclear cells, 67, 410 light chain deposition disease, 357 phagocytosis, 103 lipopolysaccharide, 91 phosphodiesterase, 97 584 Subject Index phosphorylation, 416 skin-infiltrating T cells, 555 platelet-activating factor, 143 smoking, 108 PMN, 560 soluble intercellular adhesion molecule-1, 549 pneumoconiosis, 541 soluble TNF receptor, 73 pneumonia, 120 somatic mutation, 5 PPD-spcific T cell line, 62 surfactant protein A, 367 pregnancy, 127 surfactant protein D, 367 proliferation, 481 susceptible, 45 protein tyrosine kinase, 86 synovial inflammation, 5 psoriasis, 134 systemic lupus erythematosus, 218, 253, 243 quenching, 108 T cell activation, 218 T cell apoptosis, 351 RANTES, 462 T cells, 179, 374, 534 remodelling, 114 T helper cell-dependent antibody, 35 renal interstitium, 518 T lymphocyte, 143 resistant, 45 T lymphocytes, 230, 555 respiratory burst, 97 testosterone, 410 respiratory syncytial virus, 442 TCR V8, 329 reticulin antibodies, 344 the elderly, 120 rheumatoid arthritis, 5, 13, 20, 190, 230, 427 Thy-1 molecule, 86 rheumatoid factors, 259 TNF receptors, 134 rheumatoid synovium, 481 transforming growth factor-beta, 114 ribonucleoproteins, 498 tuberculosis, 312 Ro antigen, 498 tumour necrosis factor, 91, 134, 317 RT-PCR, 67, 329 tumour necrosis factor-alpha, 20, 468, 541 type IV inhibitors, 97 sarcoidosis, 549 tyrosine phosphorylation, 179 SCID mice, 20 scleroderma, 491 Vu receptor, 5 severe combined immunodeficient mice, 253 Vk, Subgroup « chain, 357 shock, 156 varicella zoster virus, 40 sialyated proteins, 208 vasculitis, 280, 523 signal transduction, 179 visceral leishmaniasis, 454 site-directed serology, 35 vitronectin, 416 Sjégren’s syndrome, 237 VLA antigen, 13

See more

The list of books you might like

Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.
DMCA & Copyright: Dear all, most of the website is community built, users are uploading hundred of books everyday, which makes really hard for us to identify copyrighted material, please contact us if you want any material removed.
Copyright @ PDFdrive.to, 2022 | We love our users